Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 99 entries
Sorted by: Best Match Show Resources per page
Electrochemically-Driven Insertion of Biological Nanodiscs into Solid State Membrane Pores as a Basis for "Pore-In-Pore" Membranes.

Nanomaterials (Basel, Switzerland)

Farajollahi F, Seidenstücker A, Altintoprak K, Walther P, Ziemann P, Plettl A, Marti O, Wege C, Gliemann H.
PMID: 29652841
Nanomaterials (Basel). 2018 Apr 13;8(4). doi: 10.3390/nano8040237.

Nanoporous membranes are of increasing interest for many applications, such as molecular filters, biosensors, nanofluidic logic and energy conversion devices. To meet high-quality standards, e.g., in molecular separation processes, membranes with well-defined pores in terms of pore diameter and...

Cite
Farajollahi F, Seidenstücker A, Altintoprak K, et al. Electrochemically-Driven Insertion of Biological Nanodiscs into Solid State Membrane Pores as a Basis for "Pore-In-Pore" Membranes. Nanomaterials (Basel). 2018;8(4)doi: 10.3390/nano8040237.
Farajollahi, F., Seidenstücker, A., Altintoprak, K., Walther, P., Ziemann, P., Plettl, A., Marti, O., Wege, C., & Gliemann, H. (2018). Electrochemically-Driven Insertion of Biological Nanodiscs into Solid State Membrane Pores as a Basis for "Pore-In-Pore" Membranes. Nanomaterials (Basel, Switzerland), 8(4), . https://doi.org/10.3390/nano8040237
Farajollahi, Farid, et al. "Electrochemically-Driven Insertion of Biological Nanodiscs into Solid State Membrane Pores as a Basis for "Pore-In-Pore" Membranes." Nanomaterials (Basel, Switzerland) vol. 8,4 (2018). doi: https://doi.org/10.3390/nano8040237
Farajollahi F, Seidenstücker A, Altintoprak K, Walther P, Ziemann P, Plettl A, Marti O, Wege C, Gliemann H. Electrochemically-Driven Insertion of Biological Nanodiscs into Solid State Membrane Pores as a Basis for "Pore-In-Pore" Membranes. Nanomaterials (Basel). 2018 Apr 13;8(4). doi: 10.3390/nano8040237. PMID: 29652841; PMCID: PMC5923567.
Copy Download .nbib Format: NLM
[Portal vein thrombosis-treatment options].

Der Gastroenterologe : Zeitschrift fur Gastroenterologie und Hepatologie

Steib C, Guba M, Seidensticker M.
PMID: 33613777
Gastroenterologe. 2021 Feb 11;1-7. doi: 10.1007/s11377-021-00507-5. Epub 2021 Feb 11.

Portal vein thrombosis is a rare disease that describes a thrombosis in the extrahepatic or intrahepatic portion of the portal vein. Chronic liver disease or malignancy of the liver itself is often already present. However, inflammation or malignancy of...

Cite
Steib C, Guba M, Seidensticker M. Pfortaderthrombosen – therapeutische Möglichkeiten. [Portal vein thrombosis-treatment options]. Gastroenterologe. 2021;1-7doi: 10.1007/s11377-021-00507-5.
Steib, C., Guba, M., & Seidensticker, M. (2021). Pfortaderthrombosen – therapeutische Möglichkeiten. [Portal vein thrombosis-treatment options]. Der Gastroenterologe : Zeitschrift fur Gastroenterologie und Hepatologie, 1-7. https://doi.org/10.1007/s11377-021-00507-5
Steib, C, et al. "Pfortaderthrombosen – therapeutische Möglichkeiten." [Portal vein thrombosis-treatment options]. Der Gastroenterologe : Zeitschrift fur Gastroenterologie und Hepatologie vol. (2021): 1-7. doi: https://doi.org/10.1007/s11377-021-00507-5
Steib C, Guba M, Seidensticker M. Pfortaderthrombosen – therapeutische Möglichkeiten. [Portal vein thrombosis-treatment options]. Gastroenterologe. 2021 Feb 11;1-7. doi: 10.1007/s11377-021-00507-5. Epub 2021 Feb 11. German. PMID: 33613777; PMCID: PMC7877515.
Copy Download .nbib Format: NLM
Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology.

Journal of clinical medicine

Fabritius MP, Ben Khaled N, Kunz WG, Ricke J, Seidensticker M.
PMID: 34884275
J Clin Med. 2021 Nov 26;10(23). doi: 10.3390/jcm10235574.

Intrahepatic cholangiocarcinoma is a highly aggressive malignancy with an increasing incidence in recent years. Prognosis is poor and most patients are not eligible for resection at the time of initial diagnosis due to the anatomic location, inadequate hepatic reserve,...

Cite
Fabritius MP, Ben Khaled N, Kunz WG, et al. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235574.
Fabritius, M. P., Ben Khaled, N., Kunz, W. G., Ricke, J., & Seidensticker, M. (2021). Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235574
Fabritius, Matthias P, et al. "Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235574
Fabritius MP, Ben Khaled N, Kunz WG, Ricke J, Seidensticker M. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. J Clin Med. 2021 Nov 26;10(23). doi: 10.3390/jcm10235574. PMID: 34884275; PMCID: PMC8658286.
Copy Download .nbib Format: NLM
Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review.

Mycopathologia

Odysseos G, Mayr U, Bozsaki G, Seidensticker C, Ehmer U, Schmid RM, Lahmer T, Dill V.
PMID: 34718931
Mycopathologia. 2021 Oct 31; doi: 10.1007/s11046-021-00599-1. Epub 2021 Oct 31.

Invasive fungal infections in liver transplant recipients are associated with elevated morbidity and mortality and pose a challenge to the treating physicians. Despite of lacking clinical data, the use of antifungal combination therapy is often considered to improve response...

Cite
Odysseos G, Mayr U, Bozsaki G, et al. Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review. Mycopathologia. 2021;doi: 10.1007/s11046-021-00599-1.
Odysseos, G., Mayr, U., Bozsaki, G., Seidensticker, C., Ehmer, U., Schmid, R. M., Lahmer, T., & Dill, V. (2021). Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review. Mycopathologia, . https://doi.org/10.1007/s11046-021-00599-1
Odysseos, Georgios, et al. "Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review." Mycopathologia vol. (2021). doi: https://doi.org/10.1007/s11046-021-00599-1
Odysseos G, Mayr U, Bozsaki G, Seidensticker C, Ehmer U, Schmid RM, Lahmer T, Dill V. Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review. Mycopathologia. 2021 Oct 31; doi: 10.1007/s11046-021-00599-1. Epub 2021 Oct 31. PMID: 34718931.
Copy Download .nbib Format: NLM
Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology.

Journal of clinical medicine

Fabritius MP, Ben Khaled N, Kunz WG, Ricke J, Seidensticker M.
PMID: 34884275
J Clin Med. 2021 Nov 26;10(23). doi: 10.3390/jcm10235574.

Intrahepatic cholangiocarcinoma is a highly aggressive malignancy with an increasing incidence in recent years. Prognosis is poor and most patients are not eligible for resection at the time of initial diagnosis due to the anatomic location, inadequate hepatic reserve,...

Cite
Fabritius MP, Ben Khaled N, Kunz WG, et al. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235574.
Fabritius, M. P., Ben Khaled, N., Kunz, W. G., Ricke, J., & Seidensticker, M. (2021). Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235574
Fabritius, Matthias P, et al. "Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235574
Fabritius MP, Ben Khaled N, Kunz WG, Ricke J, Seidensticker M. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. J Clin Med. 2021 Nov 26;10(23). doi: 10.3390/jcm10235574. PMID: 34884275.
Copy Download .nbib Format: NLM
Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization.

Cancers

Seidensticker M, Fabritius MP, Beller J, Seidensticker R, Todica A, Ilhan H, Pech M, Heinze C, Powerski M, Damm R, Weiss A, Rueckel J, Omari J, Amthauer H, Ricke J.
PMID: 33919073
Cancers (Basel). 2021 Apr 21;13(9). doi: 10.3390/cancers13091992.

BACKGROUND: Radioembolization (RE) with yttrium-90 (

Cite
Seidensticker M, Fabritius MP, Beller J, et al. Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization. Cancers (Basel). 2021;13(9)doi: 10.3390/cancers13091992.
Seidensticker, M., Fabritius, M. P., Beller, J., Seidensticker, R., Todica, A., Ilhan, H., Pech, M., Heinze, C., Powerski, M., Damm, R., Weiss, A., Rueckel, J., Omari, J., Amthauer, H., & Ricke, J. (2021). Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization. Cancers, 13(9), . https://doi.org/10.3390/cancers13091992
Seidensticker, Max, et al. "Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization." Cancers vol. 13,9 (2021). doi: https://doi.org/10.3390/cancers13091992
Seidensticker M, Fabritius MP, Beller J, Seidensticker R, Todica A, Ilhan H, Pech M, Heinze C, Powerski M, Damm R, Weiss A, Rueckel J, Omari J, Amthauer H, Ricke J. Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization. Cancers (Basel). 2021 Apr 21;13(9). doi: 10.3390/cancers13091992. PMID: 33919073; PMCID: PMC8122451.
Copy Download .nbib Format: NLM
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial.

Journal of cancer research and clinical oncology

Öcal O, Rössler D, Gasbarrini A, Berg T, Klümpen HJ, Bargellini I, Peynircioglu B, van Delden O, Schulz C, Schütte K, Iezzi R, Pech M, Malfertheiner P, Sangro B, Ricke J, Seidensticker M.
PMID: 34541612
J Cancer Res Clin Oncol. 2021 Sep 20; doi: 10.1007/s00432-021-03803-3. Epub 2021 Sep 20.

PURPOSE: Gadoxetic acid uptake on hepatobiliary phase MRI has been shown to correlate with ß-catenin mutation in patients with HCC, which is associated with resistance to certain therapies. This study aimed to evaluate the prognostic value of gadoxetic acid...

Cite
Öcal O, Rössler D, Gasbarrini A, et al. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial. J Cancer Res Clin Oncol. 2021;doi: 10.1007/s00432-021-03803-3.
Öcal, O., Rössler, D., Gasbarrini, A., Berg, T., Klümpen, H. J., Bargellini, I., Peynircioglu, B., van Delden, O., Schulz, C., Schütte, K., Iezzi, R., Pech, M., Malfertheiner, P., Sangro, B., Ricke, J., & Seidensticker, M. (2021). Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial. Journal of cancer research and clinical oncology, . https://doi.org/10.1007/s00432-021-03803-3
Öcal, Osman, et al. "Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial." Journal of cancer research and clinical oncology vol. (2021). doi: https://doi.org/10.1007/s00432-021-03803-3
Öcal O, Rössler D, Gasbarrini A, Berg T, Klümpen HJ, Bargellini I, Peynircioglu B, van Delden O, Schulz C, Schütte K, Iezzi R, Pech M, Malfertheiner P, Sangro B, Ricke J, Seidensticker M. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial. J Cancer Res Clin Oncol. 2021 Sep 20; doi: 10.1007/s00432-021-03803-3. Epub 2021 Sep 20. PMID: 34541612.
Copy Download .nbib Format: NLM
Do the evolutionary interactions between moths and bats promote niche partitioning between bats and birds?.

Ecology and evolution

Bullington LS, Seidensticker MT, Schwab N, Ramsey PW, Stone K.
PMID: 34938500
Ecol Evol. 2021 Nov 19;11(23):17160-17178. doi: 10.1002/ece3.8355. eCollection 2021 Dec.

Ecological theory suggests that the coexistence of species is promoted by the partitioning of available resources, as in dietary niche partitioning where predators partition prey. Yet, the mechanisms underlying dietary niche partitioning are not always clear. We used fecal...

Cite
Bullington LS, Seidensticker MT, Schwab N, et al. Do the evolutionary interactions between moths and bats promote niche partitioning between bats and birds?. Ecol Evol. 2021;11(23):17160-17178doi: 10.1002/ece3.8355.
Bullington, L. S., Seidensticker, M. T., Schwab, N., Ramsey, P. W., & Stone, K. (2021). Do the evolutionary interactions between moths and bats promote niche partitioning between bats and birds?. Ecology and evolution, 11(23), 17160-17178. https://doi.org/10.1002/ece3.8355
Bullington, Lorinda S, et al. "Do the evolutionary interactions between moths and bats promote niche partitioning between bats and birds?." Ecology and evolution vol. 11,23 (2021): 17160-17178. doi: https://doi.org/10.1002/ece3.8355
Bullington LS, Seidensticker MT, Schwab N, Ramsey PW, Stone K. Do the evolutionary interactions between moths and bats promote niche partitioning between bats and birds?. Ecol Evol. 2021 Nov 19;11(23):17160-17178. doi: 10.1002/ece3.8355. eCollection 2021 Dec. PMID: 34938500; PMCID: PMC8668740.
Copy Download .nbib Format: NLM
Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer.

Cancers

Froelich MF, Schnitzer ML, Rathmann N, Tollens F, Unterrainer M, Rennebaum S, Seidensticker M, Ricke J, Rübenthaler J, Kunz WG.
PMID: 33806059
Cancers (Basel). 2021 Mar 25;13(7). doi: 10.3390/cancers13071507.

BACKGROUND: Colorectal cancer is among the most prevalent cancer entities worldwide, with every second patient developing liver metastases during their illness. For local treatment of liver metastases, a surgical approach as well as ablative treatment options, such as microwave...

Cite
Froelich MF, Schnitzer ML, Rathmann N, et al. Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers (Basel). 2021;13(7)doi: 10.3390/cancers13071507.
Froelich, M. F., Schnitzer, M. L., Rathmann, N., Tollens, F., Unterrainer, M., Rennebaum, S., Seidensticker, M., Ricke, J., Rübenthaler, J., & Kunz, W. G. (2021). Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers, 13(7), . https://doi.org/10.3390/cancers13071507
Froelich, Matthias F, et al. "Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer." Cancers vol. 13,7 (2021). doi: https://doi.org/10.3390/cancers13071507
Froelich MF, Schnitzer ML, Rathmann N, Tollens F, Unterrainer M, Rennebaum S, Seidensticker M, Ricke J, Rübenthaler J, Kunz WG. Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers (Basel). 2021 Mar 25;13(7). doi: 10.3390/cancers13071507. PMID: 33806059; PMCID: PMC8037107.
Copy Download .nbib Format: NLM
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.

European radiology

Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M.
PMID: 34467453
Eur Radiol. 2021 Aug 31; doi: 10.1007/s00330-021-08218-9. Epub 2021 Aug 31.

OBJECTIVES: To evaluate the correlation between liver enhancement on hepatobiliary phase and liver function parameters in a multicenter, multivendor study.METHODS: A total of 359 patients who underwent gadoxetic acid-enhanced MRI using a standardized protocol with various scanners within a...

Cite
Öcal O, Peynircioglu B, Loewe C, et al. Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. Eur Radiol. 2021;doi: 10.1007/s00330-021-08218-9.
Öcal, O., Peynircioglu, B., Loewe, C., van Delden, O., Vandecaveye, V., Gebauer, B., Zech, C. J., Sengel, C., Bargellini, I., Iezzi, R., Benito, A., Schütte, K., Gasbarrini, A., Seidensticker, R., Wildgruber, M., Pech, M., Malfertheiner, P., Ricke, J., & Seidensticker, M. (2021). Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. European radiology, . https://doi.org/10.1007/s00330-021-08218-9
Öcal, Osman, et al. "Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial." European radiology vol. (2021). doi: https://doi.org/10.1007/s00330-021-08218-9
Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. Eur Radiol. 2021 Aug 31; doi: 10.1007/s00330-021-08218-9. Epub 2021 Aug 31. PMID: 34467453.
Copy Download .nbib Format: NLM
Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours.

Visceral medicine

Ricke J, Westphalen CB, Seidensticker M.
PMID: 33178732
Visc Med. 2020 Oct;36(5):359-363. doi: 10.1159/000509897. Epub 2020 Oct 05.

BACKGROUND: Clinical trials have proven a survival benefit from applying local therapies for oligometastatic cancers of various origin.SUMMARY: Today, the definition of oligometa-static disease is based on limited lesion numbers and organ systems involved. Treatment guidelines by the European...

Cite
Ricke J, Westphalen CB, Seidensticker M. Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours. Visc Med. 2020;36(5):359-363doi: 10.1159/000509897.
Ricke, J., Westphalen, C. B., & Seidensticker, M. (2020). Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours. Visceral medicine, 36(5), 359-363. https://doi.org/10.1159/000509897
Ricke, Jens, et al. "Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours." Visceral medicine vol. 36,5 (2020): 359-363. doi: https://doi.org/10.1159/000509897
Ricke J, Westphalen CB, Seidensticker M. Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours. Visc Med. 2020 Oct;36(5):359-363. doi: 10.1159/000509897. Epub 2020 Oct 05. PMID: 33178732; PMCID: PMC7590770.
Copy Download .nbib Format: NLM
A novel machine learning algorithm to predict disease free survival after resection of hepatocellular carcinoma.

Annals of translational medicine

Schoenberg MB, Bucher JN, Koch D, Börner N, Hesse S, De Toni EN, Seidensticker M, Angele MK, Klein C, Bazhin AV, Werner J, Guba MO.
PMID: 32395478
Ann Transl Med. 2020 Apr;8(7):434. doi: 10.21037/atm.2020.04.16.

BACKGROUND: Due to organ shortage, liver transplantation (LT) in hepatocellular carcinoma (HCC) patients can only be offered subsidiary to other curative treatments, including liver resection (LR). We aimed at developing and validating a machine-learning algorithm (ML) to predict which...

Cite
Schoenberg MB, Bucher JN, Koch D, et al. A novel machine learning algorithm to predict disease free survival after resection of hepatocellular carcinoma. Ann Transl Med. 2020;8(7):434doi: 10.21037/atm.2020.04.16.
Schoenberg, M. B., Bucher, J. N., Koch, D., Börner, N., Hesse, S., De Toni, E. N., Seidensticker, M., Angele, M. K., Klein, C., Bazhin, A. V., Werner, J., & Guba, M. O. (2020). A novel machine learning algorithm to predict disease free survival after resection of hepatocellular carcinoma. Annals of translational medicine, 8(7), 434. https://doi.org/10.21037/atm.2020.04.16
Schoenberg, Markus Bo, et al. "A novel machine learning algorithm to predict disease free survival after resection of hepatocellular carcinoma." Annals of translational medicine vol. 8,7 (2020): 434. doi: https://doi.org/10.21037/atm.2020.04.16
Schoenberg MB, Bucher JN, Koch D, Börner N, Hesse S, De Toni EN, Seidensticker M, Angele MK, Klein C, Bazhin AV, Werner J, Guba MO. A novel machine learning algorithm to predict disease free survival after resection of hepatocellular carcinoma. Ann Transl Med. 2020 Apr;8(7):434. doi: 10.21037/atm.2020.04.16. PMID: 32395478; PMCID: PMC7210189.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 99 entries